Cosmo Bio Company,Limited (3386.T)
JPY 1154.0
(0.17%)
JPY 1154.0
(0.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.84 Billion JPY | 8.9% |
| 2022 | 1.69 Billion JPY | -3.36% |
| 2021 | 1.75 Billion JPY | -1.4% |
| 2020 | 1.78 Billion JPY | 80.34% |
| 2019 | 987 Million JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.1 Billion JPY | 13.86% |
| 2024 Q2 | 1.95 Billion JPY | -7.04% |
| 2023 Q3 | 1.77 Billion JPY | 0.57% |
| 2023 Q1 | 1.86 Billion JPY | 2728.79% |
| 2023 Q2 | 1.76 Billion JPY | -5.52% |
| 2023 FY | 1.84 Billion JPY | 8.9% |
| 2023 Q4 | 1.84 Billion JPY | 4.11% |
| 2022 Q3 | 1.56 Billion JPY | 0.0% |
| 2022 FY | 1.69 Billion JPY | -3.36% |
| 2022 Q4 | 66 Million JPY | -95.78% |
| 2021 FY | 1.75 Billion JPY | -1.4% |
| 2020 FY | 1.78 Billion JPY | 80.34% |
| 2019 FY | - JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 42.14 Billion JPY | 95.617% |
| DNA Chip Research Inc. | 250.12 Million JPY | -638.44% |
| H.U. Group Holdings, Inc. | 152.84 Billion JPY | 98.792% |
| FALCO HOLDINGS Co., Ltd. | 10.39 Billion JPY | 82.234% |
| BML, Inc. | 40.85 Billion JPY | 95.479% |
| Human Metabolome Technologies, Inc. | 656.68 Million JPY | -181.261% |
| Precision System Science Co., Ltd. | 2.25 Billion JPY | 18.045% |